Wockace-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (15mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the reduction of inflammation and edema by breaking down inflammatory mediators and promoting the drainage of inflammatory exudates. The synergistic action of these components makes Wockace-SP effective in managing conditions such as musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries. It is generally well-tolerated when used as directed; however, caution is advised in patients with a history of gastrointestinal ulcers, hepatic or renal impairment, or hypersensitivity to any component. Wockace-SP should be administered under medical supervision, and patients should adhere to prescribed dosages to minimize the risk of adverse effects. This combination tablet offers a comprehensive approach to pain and inflammation management, improving patient comfort and mobility.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety information not available for this product. Please consult your doctor or pharmacist.